InspireMD Inc. (OTC:NSPR) launched its MGuard coronary stent system in India.
The Tel Aviv-based firm’s flagship product is the first mesh-based coronary stent system available in the country, the company said.
The CE Mark approved MGuard stent is wrapped with a polymer mesh sleeve designed to protect acute MI patients against embolism. Kirloskar Technologies P. Ltd., which has already closed an initial order for the stent in India, will be InspireMD’s distributor of the product, according to the company.
"For the past two years, MGuard has met with much success in Europe and in South America. India possesses highly qualified interventional cardiologists and well-equipped hospitals, and I have full confidence that the country’s cardiologists will welcome this new solution to distal embolization, one of the most common side effects in PCI procedures during AMI," InspireMD president Asher Holzer said in prepared remarks.
Here’s a roundup of companies announcing new distribution deals and other joint ventures.
- Naviscan partners with Chindex Medical for China distribution
Naviscan Inc., a 3D Molecular Breast Imaging (MBI) developer, entered into a distribution agreement with Chindex Medical Ltd. to market and service Naviscan’s high-resolution organ-specific PET scanner in China, including Hong Kong and Macau. The agreement represents the introduction of PEM (Positron Emission Mammography), the scanner’s breast application, as a new tool available to Chinese women in their fight against breast cancer.
- MedClean inks promotion deal with Covidien
MedClean Technologies Inc. (OTC:MCLN), a provider of on-site technology for the treatment and disposal of medical waste and the destruction of confidential documents and related media, formed a co-marketing agreement with Covidien plc (NYSE:COV). With this relationship, Covidien’s national sales force for SharpSafety products will promote MedClean products and services in a complimentary manner to MedClean’s existing distributor sales force.
- CJPS inks licensing deal with J&J co.
CJPS Medical Systems entered into an exclusive worldwide technology license agreement with Independence Technology LLC, a Johnson & Johnson (NYSE:JNJ) company, to manufacture and distribute a novel Power-Assist Technology to enhance manual wheelchairs. This technology was previously integrated with a wheelchair frame, and sold by Independence Technology under the INDEPENDENCE iGLIDE brand.
- TGAC signs Caliper for sequencing
Caliper Life Sciences Inc. (NSDQ:CALP) announced a partnership with The Genome Analysis Centre (TGAC), a high throughput sequencing and analysis center based in Norwich, UK establishing TGAC as a National Reference Site. TGAC will implement Caliper’s NGS Bundle, which includes the Sciclone NGS Workstation, LabChip GX, and LabChip XT, providing TGAC with a suite of automation and microfluidic solutions for a flexible and scalable sequencing sample preparation pipeline that offers superior sample tracking and reproducibility.
- Nukona sings Integer Wireless for mHealth
Nukona of San Diego and Integer Wireless of Newport Beach, Calif. announced a relationship designed to help healthcare organizations meet those needs quickly and cost-effectively. Nukona’s services – including private app stores and app-security "wrappers" – provide enterprises with end-to-end solutions for securing their mobile devices, the data on them and the networks to which they connect. Integer Wireless specializes in designing, building and optimizing in-building and campus-wide cellular and Wi-Fi networks that provide healthcare organizations with secure, HIPAA-compliant voice, data and video communications. Announced at the Wireless-Life Sciences Alliance’s annual Convergence Summit in San Diego, the relationship will enable Nukona to expand into the wireless healthcare market with Integer Wireless’ 16 years of relationships with hospital IT managers.